Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.
Nature. 2024 May;629(8013):910-918. doi: 10.1038/s41586-024-07368-2. Epub 2024 May 1.
International differences in the incidence of many cancer types indicate the existence of carcinogen exposures that have not yet been identified by conventional epidemiology make a substantial contribution to cancer burden. In clear cell renal cell carcinoma, obesity, hypertension and tobacco smoking are risk factors, but they do not explain the geographical variation in its incidence. Underlying causes can be inferred by sequencing the genomes of cancers from populations with different incidence rates and detecting differences in patterns of somatic mutations. Here we sequenced 962 clear cell renal cell carcinomas from 11 countries with varying incidence. The somatic mutation profiles differed between countries. In Romania, Serbia and Thailand, mutational signatures characteristic of aristolochic acid compounds were present in most cases, but these were rare elsewhere. In Japan, a mutational signature of unknown cause was found in more than 70% of cases but in less than 2% elsewhere. A further mutational signature of unknown cause was ubiquitous but exhibited higher mutation loads in countries with higher incidence rates of kidney cancer. Known signatures of tobacco smoking correlated with tobacco consumption, but no signature was associated with obesity or hypertension, suggesting that non-mutagenic mechanisms of action underlie these risk factors. The results of this study indicate the existence of multiple, geographically variable, mutagenic exposures that potentially affect tens of millions of people and illustrate the opportunities for new insights into cancer causation through large-scale global cancer genomics.
国际上许多癌症类型的发病率差异表明,存在尚未被传统流行病学所识别的致癌因素,这些因素对癌症负担有很大的贡献。在透明细胞肾细胞癌中,肥胖、高血压和吸烟是风险因素,但它们并不能解释其发病率的地域差异。通过对不同发病率人群的癌症基因组进行测序,并检测体细胞突变模式的差异,可以推断出潜在的原因。在这里,我们对来自发病率不同的 11 个国家的 962 例透明细胞肾细胞癌进行了测序。这些国家的体细胞突变谱存在差异。在罗马尼亚、塞尔维亚和泰国,大多数病例中存在与马兜铃酸化合物特征一致的突变特征,但在其他地方则很少见。在日本,超过 70%的病例中存在一种未知原因的突变特征,但在其他地方则不到 2%。另一种未知原因的突变特征普遍存在,但在癌症发病率较高的国家中,其突变负荷更高。已知的吸烟相关突变特征与吸烟量相关,但没有任何突变特征与肥胖或高血压相关,这表明这些风险因素的作用机制是非诱变的。本研究结果表明,存在多种具有地域差异的潜在致突变因素,可能影响数千万人,并说明了通过大规模全球癌症基因组学深入了解癌症病因的机会。